Trial · NCT00127530
Adverse events66
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 66
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | asthenia | Musculoskeletal and connective tissue disorders | Placebo- Sugar Pill | 4 | 72 | 5 |
| other | asthenia | Musculoskeletal and connective tissue disorders | Fampridine-SR | 13 | 228 | 16 |
| other | back pain | Musculoskeletal and connective tissue disorders | Placebo- Sugar Pill | 0 | 72 | 0 |
| other | back pain | Musculoskeletal and connective tissue disorders | Fampridine-SR | 13 | 228 | 14 |
| other | balance disorder | Nervous system disorders | Placebo- Sugar Pill | 2 | 72 | 2 |
| other | balance disorder | Nervous system disorders | Fampridine-SR | 13 | 228 | 13 |
| other | dizziness | Nervous system disorders | Placebo- Sugar Pill | 4 | 72 | 4 |
| other | dizziness | Nervous system disorders | Fampridine-SR | 19 | 228 | 21 |
| other | fall | Injury, poisoning and procedural complications | Placebo- Sugar Pill | 11 | 72 | 14 |
| other | fall | Injury, poisoning and procedural complications | Fampridine-SR | 36 | 228 | 56 |
| other | fatigue | General disorders | Placebo- Sugar Pill | 2 | 72 | 2 |
| other | fatigue | General disorders | Fampridine-SR | 14 | 228 | 15 |
| other | headache | Nervous system disorders | Placebo- Sugar Pill | 4 | 72 | 4 |
| other | headache | Nervous system disorders | Fampridine-SR | 13 | 228 | 14 |
| other | insomnia | Nervous system disorders | Placebo- Sugar Pill | 3 | 72 | 3 |
| other | insomnia | Nervous system disorders | Fampridine-SR | 19 | 228 | 21 |
| other | Nausea | Gastrointestinal disorders | Placebo- Sugar Pill | 3 | 72 | 3 |
| other | Nausea | Gastrointestinal disorders | Fampridine-SR | 14 | 228 | 16 |
| other | Upper Respiratory Tract infection | Respiratory, thoracic and mediastinal disorders | Placebo- Sugar Pill | 7 | 72 | 7 |
| other | Upper Respiratory Tract infection | Respiratory, thoracic and mediastinal disorders | Fampridine-SR | 14 | 228 | 17 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00127530/events